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Abstract: Laboratory diagnostics of renal function in an experimental model of ascending 
pyelonephritis with high-virulent Escherichia coli.
In t r oduc t i on: Urinary tract infections (UTI) are caused in 95% of cases by bacteria — E. coli. 
UTIs usually are limited to the lower urinary tract, but it may also evolve into pyelonephritis and 
acute kidney injury.
 Ob j ec t i v es: The aim of this study was the laboratory evaluation of renal function in an 
experimental model of ascending pyelonephritis caused by intravesical infusion of E. coli.
 Mater ia l  &  Methods: In female Wistar rats UTI was induced by intravesical administration 
of E. coli suspension in a dose 105 c.f.u./ml (Group 1), and 107 c.f.u./ml (Group 2). On the 0,7th, 
14th and 21st day of the experiment the animals underwent the procedures of collecting blood 
and urine samples.
 Resu l ts: The results shown that in group 2 on the 7th and 14th day of the study the creatinine 
clearance decreased by 36%, and on 21th by 34%. The increase in serum uric acid concentration 
(μmol/l) in group 2 was observed on the 7th (229.75 ± 79.05) and 21st day (98.5 ± 11.33) with 
respect to day 0 (77.12 ± 11.63). In group 2 on the 7th day of the experiment there was observed the 
increased levels of potassium (mmol/l) in serum (13.5 ± 1.48) with respect to day 0 (7.74 ± 0.88). 
In group 2 in the 7th (1.06 ± 0.18) and 14th day (1.32 ± 0.26) there was noted the decreased 
excretion of potassium in the urine (mmol/24h) with respect to day 0 (3.75 ± 1.9). The decrease 
in serum sodium levels (mmol/l) in group 2 was recorded on 14th day (121.5 ± 8.7) with respect to 
day 0 (131.62 ± 4.07). Increased factional sodium excretion — FENa (%) was observed in group 2 
on 14th day (0.25 ± 0.06) with respect to day 0 (0.12 ± 0.06). 
 Conc lus i ons: Our main fi nding is that — independently of the amount bacteria present 
in urinary bladder — in this infl ammatory model there occurs inevitably acute kidney injury, 
however higher bacteria amount depicts a very clear profi le of laboratory parameters that point 
at the kidney impaired function. 
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1. INTRODUCTION
Urinary tract infection (UTI) is a bacterial infection that affects parts of the 
urinary tract, which are otherwise sterile under physiological conditions [1]. 
Due to differences in the anatomy, UTIs affect mostly women. Pyelonephritis 
(PN) is a form of UTI that has reached the pelvis of the kidney. It is a form 
of nephritis that is also referred as pyelitis. The increased incidence of UTIs 
occurs especially during sexual activity in women using vaginal inserts. Also, 
in pre- and postmenopausal period, as a consequence of hormonal imbalance, 
there is observed a resultant decreased urethral sphincter tonus that is leading 
to frequently recurrent episodes of UTIs [2]. 
The source of bacteria that are responsible for 95% of non — hospital 
UTIs, both in women and men, is the digestive tract. For 90% of UTIs cases 
the etiological factor is Escherichia coli (group: Enterobacteriaceae). E. coli is 
responsible for about 50% cases also of UTIs in hospitalized patients. The other 
etiological agents isolated in urine culture are, as follow: Klebsiella, Proteus, 
Enterobacter, Enterococcus faecalis and Staphylococcus aureus, fungi (e.g. 
Candida albicans), Chlamydia trachomatis, Neisseria gonorrhoeae, and viruses 
(e.g. Herpes simplex) [3]. 
UTIs usually are limited to the lower urinary tract. Statistics show that only 1 
in 28 cases (< 5%) undergoing uncomplicated cystitis will develop secondary 
pyelonephritis. The bacteria, colonizing the urinary bladder, are moving to the 
upper compartments via insuffi cient antirefl ux system of intramural section of 
ureters. Kidney infection undergoes from the core, spreading to the adjacent 
parts of the cortex. The presence of the pathogens in the renal parenchyma 
causes the development of infl ammation and immune activation processes that 
are changing the hemodynamic status of the kidney and lead to its functional 
impairment [4]. In case of UTIs, there is a risk of acute interstitial nephritis, 
which is one of the causes of acute kidney injury (AKI), and in some cases 
leads to chronic kidney disease [5].
Assessment of the impaired renal function is based mainly on the laboratory 
analysis of urine and blood samples. The specifi c studies allow to determine the 
degree of organ damage and are useful to monitor the effi cacy of precautionary 
treatment. One of the most frequently performed studies that are being used 
for evaluation of renal function is the assessment of glomerular fi ltration rate 
(GFR) by measuring creatinine clearance (CrCl). Due to the fact that creatinine 
is excreted only with urine and its serum concentration correlates inversely 
with GFR value, creatinine is considered as a marker of kidney function [6]. 
In addition to the diagnostic importance of creatinine clearance, in assessing 
the degree of renal damage there has also being used uric acid. Similarly 
to creatinine, uric acid is also excreted mainly by renal fi ltration (70%). The 
increase of the serum uric acid concentration, resulting from a decrease in 
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glomerular fi ltration, leads through the process of crystallization to tubular 
obstruction and local infl ammation. These properties of uric acid are pointing 
at this substance as for an important marker of acute kidney injury detection 
and assessment [7]. Often, the increase in plasma — both the creatinine 
and uric acid — is associated with electrolyte imbalance. Kidneys are the 
most important organs in sodium/potassium homeostasis. Spreading of the 
disease process leads to disturbed homeostasis and is observed as changes 
in electrolytes levels. Dyselectrolitemia in the course of kidney disease can 
lead to several complications, including arrhythmia, paralytic ileus, mental 
deterioration, etc. Hyperkalaemia is the most common cause of death in AKI 
and therefore parameters such as serum potassium and sodium concentrations 
must be strictly monitored in this condition [8].
2. AIM
The aim of this study was the laboratory evaluation — with standard renal 
function tests — of an experimental dynamic model of ascending PN caused by 
intravesical injection of high-virulent Escherichia coli strain.
3. MATERIAL AND METHODS
3 .1 .  An ima l s
The tests were performed on ten (10 weeks old) female Wistar rats that weighed 
approximately 200g (205.1 ± 10.9 g). Animals came from the animal facility of 
Faculty of Pharmacy, Jagiellonian University in Krakow. Animals were kept 
in a carefully maintained hygienic conditions in an air conditioned room with 
constant temperature 21–25ºC, with preserved twelve-hour day-night cycle and 
ad libitum access to water and food. The experiment was approved by Local 
Ethical Committee of Jagiellonian University, Cracow, Poland (resolution No 
133/2012).
3 .2 .  Resea rch  g roups  and  r esea rch  p ro toco l
According to the project’s assumptions, the animals were divided in two 
groups:
Group 1. Animals with UTI induced by intravesical infusion of 0.5 ml 
suspension of E. coli strain with high virulence in a dose of 105 c.f.u./ml.
Group 2. Animals with UTI induced by intravesical infusion of 0.5 ml 
suspension of E. coli strain with high virulence in a dose of 107 c.f.u./ml.
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The animals from both groups underwent the following procedures:
Procedure 1. Induction of ascending UTI. On the zero-day of experiment, 
the animals in general anesthesia (urethane anesthesia, Urethane, Sigma-
-Aldrich, administered i.p., in a dosage of 200 mg/kg body weight) underwent 
a procedure of placing a catheter into the bladder (sterile polyethylene catheter 
with a diameter of 1 mm and length 10 cm). Through the catheter there was 
given in two doses 0.5 ml suspension of bacteria E. coli with high virulence, 
respectively: group 1 was infected with a dose 105 c.f.u./ml, group 2 was 
infected with a dose 107 c.f.u./ml. The procedure of evoking the ascending UTI 
was carried out, after modifi cations, according Lee et al. [9].
Procedure 2. Blood sampling. On zero, 7th, 14th and 21st day of the 
experiment, the animals in general urethane anesthesia underwent a procedure 
of blood sampling. Blood was collected from the tail vein — each sample 0.5 ml 
of blood. The samples were then prepared for the biochemical analysis. 
Procedure 3. Urine sampling. In order to collect urine for biochemical 
 studies, animals on zero, 7th, 14th and 21st day of the experiment were placed 
in previously sterilized (steam sterilizer, type ASHE/A, 121°C, 15 min.) meta-
bolic cages (metabolic cage for rats 150–300 g, Tecniplast, Italy). The animals’ 
residence time lasted 24 h.
Procedure 4. Post mortem examination. On 21st day of the experiment 
the animals were sacrifi ced by an overdose of anesthetic agent — sodium 
pentobarbital (Morbital, Biowet Pulawy, i.p. administration, in a dosage of 
100 mg/kg body weight). Then there was performed a dissection, the kidneys 
and bladder were removed and placed in formalin solution (4% formalin in 
phosphate buffer solution (PBS pH 7.4) for further histological evaluation. 
The dissection was performed under sterile conditions in a laminar air fl ow, 
using previously sterilized surgical tools (steam sterilizer, type ASHE/A, 121°C, 
15 min.), as well as aseptic tools (sterile gloves, swabs, gauze).
3 .3 .  Charac t e r i s t i c s  o f  E .  co l i
The strain that was used in our study was isolated from a patient with 
pyelonephritis. It was characterized by having genes for several virulent factors: 
fi mH, papC, sfaD/E — which encode adhesins type 1 and fi mbriaes type P,S. 
Strain was having also iroN gene, responsible for encoding salmocheline — ferric 
ions receptor, and cnf-1 gene, responsible for encoding TNF1 [10].
3 .4 .  Labora to ry  ana l ys i s
During the study there were analyzed: creatinine clearance, serum uric acid, 
sodium and potassium in urine and serum, and fractional excretion of sodium. 
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All parameters analyzed in the urine were calculated on the basis of the amount 
of urine collection. The concentrations of ions in both — the serum and urine 
— were conducted on a fl ame photometer, model Corning 450. Other parameters 
were measured with using the biochemical analyzer Olympus AU 600.
3 .5 .  H i s t o l og i ca l  e va lua t i on
Organs prepared during dissection were rinsed in saline, then fi xed for 24 hours 
in 4% formalin in phosphate buffer solution (PBS pH 7.4). The preparates were 
made for evaluation under a light microscope. After deparaffi nation procedure, 
they were cut with using of microtome for slides with a thickness of 3–5 
microns. Then the preparates were stained with hematoxylin — eosin (HE) 
staining procedure. Preparates were evaluated using a magnifi cation of 100, 
200 and 400 .
3 .6 .  S ta t i s t i c s
Statistical analysis of the results was performed using Statistica 5.5 (StatSoft). 
The results for each group are shown as mean with standard deviation. For 
comparison the differences between the analyzed groups, there was used ANOVA 
test. Tukey’s HSD test was used to identify the detailed differences between 
analyzed groups. The differences between groups were considered statistically 
signifi cant for a probability level of p < 0.05. As the control for each group there 
were assumed the results obtained from zero-day, where the average value of 
the results of all 10 animals used in the experiment (there was no differences 
observed between the 0 day in both groups).
4. RESULTS
The study was performed on 10 animals, weighing 205.1 ± 10.9 g that were 
divided into two study groups. Between research groups, there was no statistical 
signifi cant differences in initial body mass (p = 0.39).
4 .1 .  H i s t o l og i ca l  e va lua t i on
In the histological preparates obtained from bladders there was observed the 
hyperinfl ation of the micro-vascular bed in group 1 and 2, and infl ammatory 
infiltration specific just for group 2. In the preparates obtained  from the 
kidneys, both in group 1 and 2, there was observed mononuclear cells chronic 
infl ammatory infi ltration.
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4 .2 .  Labora to ry  ana l ys i s
4.2.1. Creatinine clearance
Table  1
Creatinine clearance values during the experiment;
p values > 0.05 indicate that creatinine clearance did not differ signifi cantly in both groups
Parameter Day Group 1 Group 2 p value
Creatinine clearance 
(ml/min.)
 0. 1.52 ± 0.53 1.52 ± 0.53 –
 7. 1.86 ± 0.51 0.98 ± 0.18 0.055
14. 1.14 ± 0.34 0.97 ± 0.13 NS
21. 1.03 ± 0.25 1.01 ± 0.13 NS
The p value that equals 0.055 indicates a tendency to gain statistical 
signifi cance that could imply the need of further experiments on the basis of 
a larger group of animals. In comparison to the day “zero” of the experiment, 
the creatinine clearance in group 2 decreased in a manner of 36% for the 7th 
and 14th day and of 34% for the 21st day.
4.2.2. The serum concentration of uric acid
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Fig. 1. The serum concentration of uric acid during the experiment;
p values  < 0.05 for the 7th and 21st day indicate that the experimental groups 
differ statistically signifi cant
* vs. day “zero” of the experiment
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4.2.3. The serum potassium level
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Fig. 2. The serum potassium level during the experiment;
p values  < 0.05 for the 7th and 14th day indicate that the experimental groups 
differ statistically signifi cant
* vs. day “zero” of the experiment
4.2.4. The potassium excretion in the urine
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Fig. 3. The potassium excretion in the urine during the experiment;
p values  < 0.05 for the 7th and 14th day indicate that the experimental groups 
differ statistically signifi cant
* vs. day “zero” of the experiment
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4.2.5. The serum sodium level
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Fig. 4. The serum sodium level during the experiment;
p values < 0.05 for 14th and 21st day indicate that the experimental groups 
differ statistically signifi cant
* vs. day “zero” of the experiment
4.2.6. The sodium excretion in the urine
Table  2
The sodium excretion in the urine during the experiment;
p values > 0.05 indicate that the experimental groups did not differ statistically signifi cant
Parameter Day Group 1 Group 2 p value
The sodium 
excretion in the urine 
(mmol/24h)
 0. 0.35 ± 0.17 0.35 ± 0.17 –
 7. 0.29 ± 0.15 0.31 ± 0.07 NS
14. 0.31 ± 0.27 0.44 ± 0.17 NS
21. 0.21 ± 0.09 0.26 ± 0.08 NS
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4.2.7. The fractional sodium excretion (FENa)
FENa (%)
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Fig 5. The fractional excretion of sodium during the experiment; 
p values < 0.05 for the 14th day indicates that the experimental groups 
differ statistically signifi cant
* vs. day “zero” of the experiment
5. DISCUSSION
The results of this experiment show the dynamics of the infl ammation induced 
process of the kidney injury caused by two different doses of E. coli with high 
virulence strain. Selection of the etiological agent used in the experiment was 
closely related to the epidemiology of urinary tract infections, which in most 
patients is caused by a E. coli that predominate in the colon. 
Histological evaluation. Histological studies have confi rmed that within 
21 days after intravesical bacteria injection the kidneys of animals of both 
groups developed features of chronic infl ammation with mononuclear cells 
infl ammatory infi ltration. Severe injury was confi ned to the inner medulla and 
comprises features of tubular damage and scarring. These changes suggest that 
there was a passage of bacteria from urinary bladder to the upper sections of 
the urinary tract, which in turn resulted in the activation of the infl ammatory 
process within the kidney and impair their function. The vast majority of 
changes observed during the experiments occurred in group 2, infected with 
high bacteria concentration.
CrCl. On the 7th day of experiment in group 2, there was a reduction in 
creatinine clearance in a manner of 36%. Additionaly, GFR value at 64–66% was 
maintained up to 21 days after infection. The equalization of GFR in group 1 to 
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a similar level as in group 2 occurred within 21 days. These data indicate that 
the dynamics of pathological changes in the urinary tract were dose-dependent 
and inevitable. Increase of serum creatinine levels caused by a decrease in GFR 
on 7th day after infection was described by Sener at al. in experimental model 
of pyelonephritis caused by injection of bacteria in the kidney tissue. E. coli 
injected at dose of 1010 c.f.u./ml increased fi ve times creatinine level [11]. 
Malekinejad at al. in similar studies, after kidney tissue injection of the E. coli 
at dose of 106 and 107 c.f.u./ml observed increase of creatinine level by 30% 
and 40% in 3rd and 14th day after injection [12]. Thus tissue injection was 
more effective then bladder instillation. Heyman at al. in a different model of 
kidney injury — developing of AKI after administration of radiocontrast, in 
uninephrectomized, salt-depleted rats, injected with indomethacin. After 24 h 
plasma creatinine level was doubled and the creatinine clearance dropped 
from 0.7 to 0.2 ml/min. [13]. In our model, E. coli instillation at a dose of 
107 c.f.u./ml, resulted in increased creatinine level only in a manner of 20% 
and GFR decreased of 36% in 7th day. These results suggest that decrease 
in kidney function /damage/ is strictly dose — and administration route 
dependent.
Uric acid. Uric acid metabolic pathway ends up almost entirely in the 
proximal tubule. The accuracy of all of the markers based on the proximal 
tubules function, requires theirs intact function. In particular, uric acid excretion 
will increase (independently of volume status) when proximal reabsorption is 
reduced [14]. And so confi rms our study, where we observed an increase in 
group 2 in the early in the course of the experiment. The decrease in GFR in 
a manner of 36% on the 7th day causes over 100% increase in serum uric 
acid level in group 2. The elevated level of serum uric acid was maintained 
until the last day of the study in group 2, whereas in group 1, there is no 
such phenomena and a signifi cant increase in serum uric acid concentration 
appears as a single peak on 21st day after instillation. Fact that serum uric acid 
is a marker of kidney damage was observed in surgical patients, when blood 
fl ow and GFR decreased, uric acid level increased [15]. Increased uric acid 
level of about 1 mg/dl increases risk of kidney damage of about 74% [16]. Its 
reduced excretion, as a consequence of declining GFR, causes the crystallization 
within the renal tubule and enhancement of the infl ammatory processes [17]. 
Proinfl ammatory effect of uric acid occurred by activation of MCP-1 (Monocyte 
Chemoattractant Protein-1), CRP (C-reactive protein) and p38 MAPK (Mitogen-
-activated Protein Kinase). Besides proinfl ammatory effects of the uric acid, there 
was shown also its pro-oxidative feature. The elevated level of serum uric acid 
inhibits the NOS1, and — in a consequence — reduces NO and stimulation 
of the RAA system. Therefore, such cascade, may induce the damage of blood 
vessels in the kidneys and impairment of their function [18]. In our experiment, 
changes in the serum uric acid levels were correlated with the decrease of GFR 
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and both of the changes are dose-dependent when it’s about the concentration 
of E. coli injections. Highest increase of serum uric acid level occurred on 7th 
day of infection in group 2.
Electrolytes. Observed in our study decline in GFR value in this particular 
model of kidneys’ injury induced also changes in water balance and electro-
lytes abnormalities [19]. Tubular ions transport is impaired by mediators of 
infl ammation. The most important pro — infl ammatory cytokines and mediators 
are in that case IL-1 and PGE2 that reduce activity of Na-K-ATPase and induce 
changes in kidney hemodynamics [20]. Hiperkalaemia and hyponatraemia 
— observed in our group 2 — confi rmed these observations that the cause of 
the electrolytes abnormality is renal dysfunction [21]. Electrolytes imbalance 
occurred not only in pyelitis but also in all cases of AKI [22]. Signifi cant changes 
in serum potassium levels appear in our experiment early on the 7th day of the 
experiment. The increase in serum potassium excretion correlates with the daily 
urine production, as well as with the decrease of GFR value. Hiperkalaemia 
that was resulting from the GFR value decrease, is a characteristic symptom 
of chronic kidney injury. Hsieh at al. found that decrease of the eGFR value of 
about 10ml/min increases serum potassium level of about 0,117 mmol/l [23]. 
Hyponatraemia has occurred after two weeks of the experiment and was 
correlating with a fractionated sodium excretion that indicates increased renal 
damage [24].
FENa. The FENa is considered the most accurate clinical diagnostic test 
to differentiate between prerenal and renal disease like acute tubular necrosis 
(ATN) that are considered as two most common causes of AKI [25]. The FENa 
and the urine sodium concentration are usually measured to determine if 
a patient’s effective fl uid volume isn’t depleted [26]. In our experiments lowered 
level of serum sodium concentration occurred only in group 2 after two weeks 
of infection. The relatively higher FENa in group 2 of our experiments can be 
observed as a result of one or both of the following factors: inappropriate sodium 
wasting due to tubular infl ammatory damage and an inappropriate response 
to volume expansion of fl uids. The former is most likely to be important early 
in the disease when nephrons that are still fi ltering have impaired tubular 
function. Volume expansion may be more important in late form of pyelonephritis 
with established tubular damage and normal tissue perfusion in the healthy 
regions. At the end of infl ammatory process most of the damaged nephrons 
are excluded and nonfunctioning. Urine output results from a number of well-
-preserved nephrons. In this period, the maintenance of body sodium balance 
requires a higher FENa [27].
The newest data are pointing at a lack of information about relationship 
between dose of bacteria E. coli and biomarkers of kidneys’ function. Our main 
fi nding is that — independently of the amount of bacteria present in urinary 
bladder — in this infl ammatory model there occurs inevitable kidney injury. 
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Moreover, higher bacteria concentrations cause the more pronounced increase 
in the laboratory markers of renal function.
Acute renal failure may develop after the noxious stimulus response within 
a few hours to several days [28]. In our experiments, in both groups, this 
time ranges from 1 to 14 days. The standard parameters analyzed in the 
experiment, like: the decrease of creatinine clearance, the increase of serum 
uric acid level, the increase of serum potassium and the decrease of potassium 
urine level were observed within 7 days after infection. After two weeks, sodium 
concentration imbalance occurs with the decreased serum sodium levels and 
increased excretion of fractional sodium. In order to answer the question 
— how fast is the dynamics of the infl ammatory process and at what dose the 
etiological agent is needed to see advanced AKI — it is necessary to repeat the 
experiments with using new markers of AKI, as well as to monitor the renal 
function parameters that would be based on shorter time intervals.
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